Clinical research on the usefulness of LC-1000 (detached cell analyzer) as a diagnostic support system for cervical cancer

Clinical research on the usefulness of LC-1000 (detached cell analyzer) as a diagnostic support system for cervical cancer - Clinical research on the usefulness of LC-1000

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047305

Enrollment

185

Registered

2022-06-01

Start date

2020-06-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients with cytological abnormalities of ASC-US or higher

Exclusion criteria

Exclusion criteria: Those who could not give consent. Those who have had invasive cervical cancer in the past.

Design outcomes

Primary

Measure	Time frame
Comparison of LC-1000 Rank Classification Results with HPV Genotyping Results for Risk of Cervical Intraepithelial Tumor Progression	—

Countries

Japan

Contacts

Public ContactMasaru Nakamura

Fujita Health University Advanced Robotic and Endoscopic Surgery

masaru.nakamura@fujita-hu.ac.jp0562932111

Outcome results